Pathway Financial Advisors LLC Trims Position in Procter & Gamble Company (The) $PG

Pathway Financial Advisors LLC lessened its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 2.5% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,070 shares of the company’s stock after selling 105 shares during the quarter. Pathway Financial Advisors LLC’s holdings in Procter & Gamble were worth $648,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the business. Kingstone Capital Partners Texas LLC lifted its stake in shares of Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Northern Trust Corp lifted its stake in shares of Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock worth $5,051,930,000 after purchasing an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. lifted its stake in shares of Procter & Gamble by 3.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after purchasing an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Procter & Gamble by 6.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock worth $2,947,146,000 after purchasing an additional 1,018,865 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Down 0.6%

Shares of NYSE PG opened at $149.69 on Monday. Procter & Gamble Company has a 12-month low of $149.45 and a 12-month high of $180.43. The company has a market cap of $350.34 billion, a P/E ratio of 22.99, a P/E/G ratio of 3.97 and a beta of 0.36. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The stock has a fifty day moving average price of $155.24 and a 200 day moving average price of $159.41.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same period in the prior year, the firm earned $1.40 EPS. The firm’s quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently commented on PG. BNP Paribas restated an “outperform” rating and set a $177.00 price objective on shares of Procter & Gamble in a report on Friday, August 15th. Evercore ISI restated an “in-line” rating and set a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Berenberg Bank upped their price objective on Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a report on Wednesday, September 17th. UBS Group dropped their price objective on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a report on Wednesday. Finally, Wells Fargo & Company dropped their price objective on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a report on Thursday, September 25th. Eleven investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $172.21.

Insider Transactions at Procter & Gamble

In related news, CFO Andre Schulten sold 4,252 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $647,281.96. Following the completion of the sale, the chief financial officer directly owned 53,992 shares in the company, valued at approximately $8,219,202.16. This represents a 7.30% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jon R. Moeller sold 11,684 shares of the stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $1,778,655.32. Following the completion of the sale, the chief executive officer owned 319,932 shares of the company’s stock, valued at approximately $48,703,248.36. This represents a 3.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 149,763 shares of company stock worth $23,421,279 in the last quarter. 0.20% of the stock is owned by corporate insiders.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.